Syncytin immunoreactivity in colorectal cancer: Potential prognostic impact
✍ Scribed by Julie Mou Larsen; Ib Jarle Christensen; Hans Jørgen Nielsen; Ulla Hansen; Bolette Bjerregaard; Jan Fredrik Talts; Lars-Inge Larsson
- Book ID
- 116335152
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 360 KB
- Volume
- 280
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In addition to the tumor suppressor gene p53, Cyclin Dependent Kinases (CDK) are well known to influence the cell cycle in normal human tissues and various neoplasias as well. The purpose of our present study was to evaluate the expression of the CDK-inhibitor p21/waf1/cip1 in colorectal cancer with
Using antibodies to type IV collagen, basement membrane (BM) deposition at the tumor-stromal border was studied in 163 cases of colorectal carcinomas. Immunoreactivity was scored semiquantitatively as moderate/extensive versus limited BM deposition and correlated with Dukes' stages and survival data